Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BioNeutral Group, Inc | Financial_Report.xls |
| EX-10.42 - NOTE SATISFACTION AND EXCHANGE AGREEMENT BETWEEN THE COMPANY AND HERB KOZLOV - BioNeutral Group, Inc | f10q0413ex10xxxxii_bioneutr.htm |
| 10-Q - QUARTERLY REPORT - BioNeutral Group, Inc | f10q0413_bioneutral.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002* - BioNeutral Group, Inc | f10q0413ex31i_bioneutral.htm |
EXHIBIT 32.1
CERTIFICATIONS
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of BioNeutral Group, Inc. (the “Company”) on Form 10-Q for the period ended April 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Lowenthal, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
|
1.
|
The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
June 24, 2013
|
/s/ Mark Lowenthal
|
||
|
Name:
|
Mark Lowenthal
|
||
|
Title:
|
Interim Chief Executive Officer
(Principal Executive Officer and Principal Financial Officer)
|
||